Moderna Starts Testing COVID-19 Vaccine in Younger Children
TUESDAY, March 16, 2021 -- Moderna has launched a study of its COVID-19 vaccine in children younger than 12 years, including babies as young as 6 months.
The company expects to enroll 6,750 healthy children in the United States and Canada, but Moderna spokeswoman Colleen Hussey did not reveal how many had already been signed up or received their first shots, The New York Times reported.
In another study, Moderna is testing its vaccine in 3,000 older children, ages 12 to 17 years, and may have results by summer. But even if the results are favorable, the vaccine would not be immediately available because it would have to be approved for use in children.
"There's a huge demand to find out about vaccinating kids and what it does," David Wohl, M.D., medical director of the vaccine clinic at the University of North Carolina, told The Times. He is not involved in the studies.
© 2021 HealthDay. All rights reserved.
Posted: March 2021
Further Support and Information on COVID-19
Read this next
WEDNESDAY, April 21, 2021 -- Antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are detectable in the breast milk of lactating women up to 80 days...
WEDNESDAY, April 21, 2021 -- A pathogenic platelet factor 4 (PF4)-dependent syndrome has been observed rarely after administration of the ChAdOx1 nCoV-19 vaccine, according to a...
WEDNESDAY, April 21, 2021 -- Sex disparities in COVID-19 mortality do not hold across racial groups, according to a study published online April 5 in the Journal of General...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.